Dr. Caroline Baumal
Chief Medical Officer
Other
Executive changes
Earnings-call appearances
-
Apellis Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-13
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-01-08
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-10-05
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-07-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-03-31
Apellis Pharmaceuticals, Inc. (APLS)